New treatments for systemic lupus erythematosus
New therapies for systemic lupus erythematosus are rare. This is because of the complexity of the disease and its varied presentations. There are many variables and a variety of measurement scales that must be satisfied before a new agent is approved for use in humans. Attempts are ongoing to develo...
Main Author: | Robert George Lahita |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=1;spage=48;epage=51;aulast=Lahita |
Similar Items
-
What's New in the Treatment of Systemic Lupus Erythematosus
by: Stamatis Nick Liossis, et al.
Published: (2021-03-01) -
Specific features of regulatory T cells in patients with systemic lupus erythematosus
by: A. V. Torgashina, et al.
Published: (2018-12-01) -
Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date
by: Lenert A, et al.
Published: (2017-03-01) -
Emerging B-Cell Therapies in Systemic Lupus Erythematosus
by: Bag-Ozbek A, et al.
Published: (2021-01-01) -
Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus
by: Susan Malkiel, et al.
Published: (2018-03-01)